304 related articles for article (PubMed ID: 23801138)
41. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
[TBL] [Abstract][Full Text] [Related]
42. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC
Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab.
Kakiuchi S; Akiyama H; Harima I; Takagi I; Rikitake J; Kozuki Y; Inaba M; Fujiwara H; Kurose N; Yamada S; Masaki Y
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837418
[TBL] [Abstract][Full Text] [Related]
44. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
[TBL] [Abstract][Full Text] [Related]
45. A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgery.
Nagano M; Matsumoto J
Surg Case Rep; 2016 Dec; 2(1):61. PubMed ID: 27316721
[TBL] [Abstract][Full Text] [Related]
46. [TAFRO syndrome and monoclonal gammapathy: Uncommon association!].
Naifar M; Messedi M; Elleuch A; Snoussi M; Gouiaa N; Turki M; Lahiani A; Boudawara T; Bahloul Z; Ayedi F
Curr Res Transl Med; 2016; 64(1):43-7. PubMed ID: 27140598
[TBL] [Abstract][Full Text] [Related]
47. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
48. Liver cirrhosis in a child associated with Castleman's disease: A case report.
Kobayashi S; Inui A; Tsunoda T; Umetsu S; Sogo T; Mori M; Shinkai M; Fujisawa T
World J Clin Cases; 2020 May; 8(9):1656-1665. PubMed ID: 32432144
[TBL] [Abstract][Full Text] [Related]
49. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
50. Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO.
Abe N; Kono M; Kono M; Ohnishi N; Sato T; Tarumi M; Yoshimura M; Sato T; Karino K; Shimizu Y; Fujieda Y; Kato M; Hasebe R; Oku K; Murakami M; Atsumi T
Br J Haematol; 2022 Mar; 196(5):1194-1204. PubMed ID: 34873687
[TBL] [Abstract][Full Text] [Related]
51. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
52. [Castleman disease].
Meignin V; Calvani J; Oksenhendler E
Ann Pathol; 2023 Jan; 43(1):13-24. PubMed ID: 36192235
[TBL] [Abstract][Full Text] [Related]
53. TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review.
Grange L; Chalayer E; Boutboul D; Paul S; Galicier L; Gramont B; Killian M
Autoimmun Rev; 2022 Aug; 21(8):103137. PubMed ID: 35803499
[TBL] [Abstract][Full Text] [Related]
54. [TAFRO syndrome, variant of Castleman's disease: case report].
Sánchez-Pardo S; Rojas-Holguín DF; Choi-Park I; Osorio-Ramírez JA; Bolívar-Mejía A
Rev Med Inst Mex Seguro Soc; 2020 Nov; 58(6):734-739. PubMed ID: 34705406
[TBL] [Abstract][Full Text] [Related]
55. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.
Iwaki N; Gion Y; Kondo E; Kawano M; Masunari T; Moro H; Nikkuni K; Takai K; Hagihara M; Hashimoto Y; Yokota K; Okamoto M; Nakao S; Yoshino T; Sato Y
Sci Rep; 2017 Feb; 7():42316. PubMed ID: 28205564
[TBL] [Abstract][Full Text] [Related]
56. Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.
Iizuka-Honma H; Takizawa H; Nitta H; Mitsumori T; Noguchi M
J Clin Exp Hematop; 2023; 63(1):32-36. PubMed ID: 36990774
[TBL] [Abstract][Full Text] [Related]
57. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
[TBL] [Abstract][Full Text] [Related]
58. Stepwise Treatment for TAFRO Syndrome.
Ide M; Yokoyama T; Ishikawa M; Kojima K
J Med Cases; 2023 Nov; 14(11):369-377. PubMed ID: 38029058
[TBL] [Abstract][Full Text] [Related]
59. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
[TBL] [Abstract][Full Text] [Related]
60. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]